Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health
Funding to accelerate commercialization of Re-Q and expand pipeline built on breakthrough science targeting the biology of skin aging CARLSBAD, Calif., June 23, 2026 /PRNewswire/ -- Rapalogix Health, a biotechnology company pioneering a new category of longevity-based skin health, today...
Funding to accelerate commercialization of Re-Q and expand pipeline built on breakthrough science targeting the biology of skin aging CARLSBAD, Calif., June 23, 2026 /PRNewswire/ -- Rapalogix Health, a biotechnology company pioneering a new category of longevity-based skin health, today...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.